![5-[[(1S,2S)-2-(6-azanylhexanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid in PDB entry 4cgi, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/4cgi_entity_4_side_image-200x200.png "Homo dimeric assembly 1 of PDB entry <span class='highlight'>4cgi</span> contains 2 copies of <span class='highlight'>5-[[(1S,2S)-2-(6-azanylhexanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid</span>. Side view.")
![5-[[(1S,2S)-2-(6-azanylhexanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid in PDB entry 4cgi, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/4cgi_entity_4_top_image-200x200.png "Homo dimeric assembly 1 of PDB entry <span class='highlight'>4cgi</span> contains 2 copies of <span class='highlight'>5-[[(1S,2S)-2-(6-azanylhexanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid</span>. Top view.")
Environment details NEW
NZL 1214 bound to chain B
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.